Commonwealth Equity Services »

Castle Biosciences shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $256k 6.6k 38.90
2023-09-30 $190k 11k 16.85
2023-06-30 $210k 15k 13.73
2022-03-31 $206k 4.6k 44.75
2021-09-30 $337k 5.1k 66.46
2021-06-30 $372k 5.1k 73.27
2021-03-31 $265k 3.9k 68.35

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Growth Etf Shs Creation Uni (CGGR)

View all positions for Commonwealth Equity Services

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Rtw Investments
Principal Financial Group
Portolan Capital Management
Dimensional Fund Advisors
Summit Partners Public Asset Management
State Street Corporation
Geode Capital Management
Palisade Capital Management
AIGH Capital Management
Allianz Asset Management
Millennium Management
Daniel D. Thurber
Nuveen

View all funds holding Castle Biosciences